NetworkNewsBreaks Archive - NetworkNewsWire

TuesdayOct 04, 2022 4:21 pm

NetworkNewsBreaks – ROTH’s Healthcare Opportunities Conference to Showcase ~25 Carefully Selected Companies

ROTH Capital Partners, a full service investment bank focused on serving emerging growth companies and their investors, today announced that it will host its Inaugural Healthcare Opportunities Conference in New York City on Oct. 6, 2022. The conference will feature approximately 25 public healthcare companies that have been selected by ROTH’s research analysts and provide C-level executives the opportunity to closely interact with pre-qualified institutional investors and healthcare industry professionals. The event will have a multiple sub-sector focus with participating companies operating in biotechnology, pharmaceuticals, medical technologies, oncology and mental health therapeutics. “Most healthcare conferences are skewed toward companies whose…

TuesdayOct 04, 2022 2:49 pm

NetworkNewsBreaks – Astra Energy Inc. (ASRE) Commences Trading on the OTCQB Venture Market

Astra Energy (OTCQB: ASRE), a global integrated energy solutions provider specializing in clean and renewable energy and technology, today announced that its public market listing was successfully upgraded from the OTC Pink Sheet Open Market to the OTCQB(R) Venture Market (“OTCQB”) by the OTC Markets Group Inc. The company’s listing of its common shares was upgraded on Friday, Sept. 30, and will continue to trade under the ASRE symbol. “This market listing upgrade serves as an important milestone toward further expansion of our market presence in North America and internationally, providing a broader opportunity to attract a larger shareholder audience,”…

TuesdayOct 04, 2022 2:44 pm

NetworkNewsBreaks – Riot Blockchain Inc. (NASDAQ: RIOT) Reports on September 2022 Production, Operations

Riot Blockchain (NASDAQ: RIOT), an industry leader in Bitcoin mining and data center hosting, has released a status update for production and operations for September 2022. Highlights of the report note that Riot produced 355 BTC, an estimated 13% decrease compared to September 2021, and at month-end, Riot held approximately 6,775 BTC — all produced by the company’s self-mining operations. The company also sold 300 BTC during the month, resulting in about $6.1 million net proceeds, and deployed a fleet of 55,728 miners, with a hash rate capacity of 5.6 exahash per second (“EH/s”). As for infrastructure, the company’s engineering and…

TuesdayOct 04, 2022 2:40 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Show to Take the Spotlight in Chicago

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that its Robot Roadshow will land at Mark Goodman & Associates, 400 N Elizabeth in Chicago, Illinois, on Oct. 7, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Chicago Roadshow landing will be guided by Knightscope experts both virtually and in person. Visitors will be able to interact directly with each of the ASRs and see the Knightscope Security…

TuesdayOct 04, 2022 2:26 pm

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Issues Update on GrowTEC RNG Expansion Project

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) today announced that construction on phase 1 of the GrowTEC RNG Expansion Project is 80% complete and tracking ahead of schedule. An operating biogas facility, GrowTEC focuses on sustainable agriculture through the conversion of organic waste to soil amendments and clean energy. Since EverGen acquired a 67% interest and assumed operatorship earlier this year, it has been successful to date in implementing the project designed to upgrade existing biogas and power production to renewable natural gas (“RNG”). “We are thrilled with the pace at which our team has delivered this project,” said Chase Edgelow, CEO…

TuesdayOct 04, 2022 12:00 pm

NetworkNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Positioned for Continued Growth Amid Prevailing Market Trends

Freight Technologies (NASDAQ: FRGT), a company that simplifies cross-border shipping and daily carrier operations through its B2B marketplace Fr8App, recently filed a Form F-1 with the Securities and Exchange Commission (“SEC”). “In the recently filed Form F-1, Fr8Tech, a British Virgin Islands-incorporated technology company developing supply chain optimization and automation solutions and providing its Fr8App platform for B2B cross-border shipping, registered more than 19 million ordinary shares for resale by selling shareholders identified in the form… Fr8Tech CEO Javier Selgas commented, ‘We are incredibly proud of our team, and thank them for their work and dedication to deliver our F-1…

MondayOct 03, 2022 1:57 pm

NetworkNewsBreaks – Crypto Assets Conference to Collaborate with IBN for Upcoming German Event

Crypto Assets Conference (“CAC22B"), one of the leading blockchain technology conferences in Europe, will be partnering with InvestorBrandNetwork (“IBN”) to provide coverage of its Germany event. The event is scheduled for Oct. 18–19, 2022, and will be held at the Frankfurt School Blockchain Center. According to the announcement, the two-day event is designed to offer invaluable knowledge focused on the latest market trends and research findings. The conference agenda is broken into two tracks, one for each day. The theme for day 1 is “Bitcoin, Crypto Assets, Smart Contract Platform, DeFi, Metaverse, NFTs and Inflation”; day 2 theme is “Digital Securities,…

MondayOct 03, 2022 1:40 pm

NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Preparing for Ketamine Tech FDA Pre-Investigational New Drug Package

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, is collaborating with Premier Consulting to prepare a pre-investigational new drug (“IND”) package and meeting request with the United States Food and Drug Administration (FDA) for SPC-26, the company’s novel topical formulation of ketamine for the treatment of fibromyalgia. The company is planning to pursue a 505(b)(2) regulatory pathway for novel topical formulation of ketamine. According to the company, Premier Consulting will assist with the development of SILO’s nonclinical, clinical, clinical pharmacology, and biopharmaceutics strategy and program to be proposed to the FDA.…

MondayOct 03, 2022 1:30 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) K5 ASR to Enhance Security at Orange County Convention Center

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced a partnership with the award-winning, Orlando, Florida-based Orange County Convention Center (“OCCC” or the “Center”). A leader in creating safe, memorable experiences for visitors from around the world, the OCCC will begin utilizing Knightscope’s K5 Autonomous Security Robot (“ASR”) to enhance security and operational efficiency at the massive facility. According to the announcement, this represents Knightscope’s first-ever convention center contract and marks the company’s entrance into this area of the security market. “We are thrilled that Knightscope and the OCCC developed this…

MondayOct 03, 2022 12:57 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Poised to Bring ‘Potentially Impactful’ Therapy to GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a preclinical stage biotechnology company specializing in developing novel treatments for brain tumors, has focused on its lead drug candidate, Berubicin, to potentially treat glioblastoma (“GBM”). “CNS has since made significant headway, even receiving FDA Fast Track Designation, which now offers it an accelerated path to approval for Berubicin. ‘With this designation, we now have an accelerated pathway to approval for Berubicin and a clear opportunity to more expediently bring this potentially impactful investigational therapy to individuals battling this challenging disease,’ noted CNS CEO John Climaco. GBM’s median survival from initial diagnosis is less than 15…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks